http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101765575-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 |
| filingDate | 2016-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101765575-B1 |
| titleOfInvention | Pharmaceutical composition for inhibiting a growth of cancer stem cells comprising aldehyde inhibitor and biguanide compounds |
| abstract | The present invention relates to a pharmaceutical composition for inhibiting the growth of cancer stem cells comprising an aldehyde inhibitor and a biguanide-based compound. The pharmaceutical composition according to the present invention effectively inhibits the growth of cancer stem cells such as neuralgia by using an aldehyde inhibitor and a biguanide-based compound, and inhibits cancer cell such as cancer, such as cancer cell proliferation, invasion and metastasis And / or treated. |
| priorityDate | 2015-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.